Latest News about RGNX
Recent news which mentions RGNX
Ocular Gene Therapy: Regenxbio Data Shows Consistent Preservation Of Visual Acuity, Retinal Thickness
January 17, 2024
From Benzinga
Progress Software Posts Strong Q4 Results, Joins Impinj, REGENXBIO And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
January 17, 2024
From Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
From Benzinga
Boeing, Pacific Biosciences of California And Other Big Stocks Moving Lower On Monday
January 08, 2024
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 30, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 05, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Monday
September 11, 2023
From Benzinga
RegenXbio's Potential Blockbuster: Analyst is Bullish On Stock Citing Potential Gains From AAV Gene Therapies Resurgence
June 20, 2023
From Benzinga
From Benzinga
From Benzinga
Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 16, 2023
From Benzinga
Tickers
RGNX
From Motley Fool
From Benzinga
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
March 01, 2023
From Benzinga
Earnings Scheduled For February 28, 2023
February 28, 2023
From Benzinga
Regenxbio Says Diabetic Retinopathy Gene Therapy Shows Meaningful Improvements In Disease Severity
November 03, 2022
Tickers
RGNX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.